Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market

The technologies in needle free injection system has undergone significant change in recent years, with powdered based to laser based needle free injection. The rising wave of new technologies such as laser and jet based needle free injection system are creating significant potential in various medical platforms as it is an effective alternative and novel technique to introduce drugs into a patient’s body without invading the skin with a needle.

In needle free injection system market, various technologies such as jet-based, spring-based, laser-powered, and vibration-based technologies are used in the vaccine delivery, insulin delivery, pain management, and pediatric injections applications. Increasing incidence of communicable diseases due to needle stick injuries and rise in demand for self-injection devices are creating new opportunities for various needle free injection system technologies.

Some of the latest technological developments by various countries in the needle free injection system market are as follows:

• United States: PharmaJet is leading initiatives in needle-free injection system technology. PharmaJet has announced advancements in its jet-based injection technology, offering painless and precise vaccine delivery for various healthcare applications.
• Germany: Zogenix is investing in needle-free injection system technology development. Zogenix has introduced laser-powered needle-free injection systems for pain management and drug delivery in healthcare settings.
• Japan: Terumo Corporation is driving innovation in needle-free injection system technologies. Terumo Corporation is focusing on laser-powered needle-free injection systems for drug delivery and pain management applications. The Japanese government has set targets to promote the adoption of needle-free injection technologies in public health programs to improve vaccination coverage and reduce needle phobia.
• China: Changchun Borch Biotech Co., Ltd. and Bespak China are investing in needle-free injection system technology innovation. Changchun Borch Biotech Co., Ltd. specializes in jet-based needle-free injection systems for the veterinary medicine and human healthcare applications. Bespak China is focusing on spring-based needle-free injection systems for insulin delivery and vaccine administration.

This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the needle free injection system market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.

 

 

 

 

 

The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global needle free injection system by application, technology, and region as follows:

Technology Readiness by Technology Type

Competitive Intensity and Regulatory Compliance

Disruption Potential by Technology Type

Trends and Forecasts by Technology [$M shipment analysis from 2018 to 2030]:

Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:

Technology Trends and Forecasts by Region [$M shipment analysis for 2018 to 2030]:

Latest Developments and innovations in the Needle Free Injection Technologies

Companies / Ecosystems

Strategic Opportunities by Technology Type

Some of the needle free injection system companies profiled in this report include Antares Pharma, Endo International, Pharmajet, Medical International Technology, Injex Pharma, Valeritas, European Pharma Group, Penject Corporation, and Crossject.

Below are the latest technological developments from top companies in the needle free injection system market:

• PharmaJet recently announced the FDA clearance of its Stratis 0.5mL Needle-free Jet Injector for use with Afluria influenza vaccine. The device utilizes PharmaJet’s needle-free technology to deliver vaccines through a high-velocity fluid stream, offering a painless and efficient alternative to traditional needle injections.
• Portal Instruments unveiled its latest advancements in spring-based needle-free injection technology. The company's device, Portal Patch, utilizes a spring mechanism to administer medications subcutaneously without the need for needles. Portal Patch offers precise dosage delivery and enhanced patient comfort.
• Zogenix announced the successful completion of a phase 3 clinical trial for its Rizaport® M207, a laser-powered needle-free migraine treatment. The device delivers the drug sumatriptan through the skin using a brief laser pulse, providing rapid relief for migraine sufferers without the need for needles.
• Inovio Pharmaceuticals showcased its latest developments in vibration-based needle-free injection technology. The company's device, Cellectra® 3PSP, utilizes a combination of electrical pulses and vibration to deliver DNA vaccines directly into the skin, offering a painless and efficient method of immunization.

This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the needle free injection system market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in needle free injection system market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in needle free injection system market?
Q.6 What are the latest developments in needle free injection system technologies? Which companies are leading these developments? 
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this needle free injection system market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this needle free injection system space?